Allergan Pharmaceuticals Ireland

Ukraine

All drugs from this manufacturer

  • BOTOX® COMPLEX BOTULINUM TOXIN TYPE A (FROM CLOSTRIDIUM BOTULINUM)

    The drug is used to treat various neurological disorders (e.g., muscle spasticity in children and adults, chronic migraine, blepharospasm), bladder function disorders (overactivity and urinary incontinence), as well as for the correction of facial wrinkles and the treatment of excessive sweating (hyperhidrosis).

    Dosage form: powder for injection solution

    Active substance Dosage
    botulinum toxin type a 200 units-Allergan

    ATC: M03AX01

  • The drug is used to treat various neurological disorders (e.g., muscle spasticity in children and adults, blepharospasm, cervical dystonia, chronic migraine), bladder function disorders (overactivity and urinary incontinence), as well as for the treatment of hyperhidrosis (excessive sweating) and the correction of certain types of facial wrinkles.

    Dosage form: powder for injection solution

    Active substance Dosage
    botulinum toxin type a 100 units-Allergan

    ATC: M03AX01

  • The drug is used to reduce high intraocular pressure in patients with chronic open-angle glaucoma and ocular hypertension if other treatments do not provide sufficient effect.

    Dosage form: drops, ophthalmic

    Active substance Dosage
    brimonidine 2.0 mg/ml
    timolol 5.0 mg/ml

    ATC: S01ED51

  • The drug is used to reduce high intraocular pressure in patients with open-angle glaucoma and ocular hypertension if other medications do not provide sufficient effect.

    Dosage form: drops, ophthalmic

    Active substance Dosage
    bimatoprost 0.3 mg/ml
    timolol 5 mg/ml

    ATC: S01ED51

  • The drug is used to reduce elevated intraocular pressure in adults with chronic open-angle glaucoma and ocular hypertension.

    Dosage form: drops, ophthalmic solution

    Active substance Dosage
    bimatoprost 0.1 mg/ml

    ATC: S01EE03

  • The drug is used for the treatment of adult patients with macular edema (resulting from central or branch retinal vein occlusion), non-infectious uveitis (inflammation of the posterior segment of the eye), as well as diabetic macular edema, if other treatment methods are unsuitable or ineffective.

    Dosage form: implant, intravitreal

    Active substance Dosage
    dexamethasone 700 mcg

    ATC: S01BA01